Latest News

13 Jan 2014 FDA Approves Trametinib in Combination with Dabrafenib for Advanced Melanoma Melanoma - Anticancer agents & Biologic therapy
13 Jan 2014 The Impact of Personalised Medicine in Elderly Patients with Cancer Personalised medicine - Cancer in Special Situations
08 Jan 2014 Personalised Medicine in Melanoma Personalised medicine - Melanoma
06 Jan 2014 Biologicals in the Treatment of Haematological Malignancies Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jan 2014 Personalised Medicine in Carcinoma of Unknown Primary Personalised medicine - Carcinoma of unknown primary site
02 Jan 2014 Hints for Personalised Medicine in Genitourinary Cancers Genitourinary cancers - Personalised medicine
31 Dec 2013 FDA Authorised First Next-Generation Sequencer Personalised medicine
30 Dec 2013 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Cabozantinib for the Treatment of Medullary Thyroid Cancer Endocrine cancers - Anticancer agents & Biologic therapy
20 Dec 2013 NSCLC Maintenance Therapy: Bevacizumab or Pemetrexed? Lung and other thoracic tumours
19 Dec 2013 Systems medicine paves the way for improved treatment for AML patients Personalised medicine - Translational research - Haematologic malignancies
18 Dec 2013 Misunderstanding of Palliative Care Palliative and supportive care
17 Dec 2013 ESMO Signalling Pathways Symposium 2014: targeting the PI3K/AKT/mTOR pathway
17 Dec 2013 A Study of Anastrozole in Breast Cancer Chemoprevention Breast cancer - Cancer prevention
16 Dec 2013 Obinutuzumab/Chlorambucil in the First-Line Treatment of Older CLL Patients Cancer in Special Situations - Haematologic malignancies - Anticancer agents & Biologic therapy